20
Nov
2020

Share

Looking across the earnings valley

Those companies which record the largest retreat in profitability during a recession often see the biggest rebounds in subsequent years. Company reports and consensus Earning Per Share (EPS) estimates for the US S&P500 market points to a similar experience for this cycle.

And despite the daily COVID-19 infections numbers averaging approximately 600,000 or double the number in August, confidence in this view has been increased with the recent announcements from both Pfizer and Moderna of what appears to be a vaccine.

In this blog, we have broken the S&P500 market down into four broad categories, being Technology, Non- Cyclicals, Financials and Cyclicals.

Screen Shot 2020-11-20 at 10.28.57 am

 

Source: Credit Suisse

The table above illustrates how Cyclicals, for example, are expected to record a 48 per cent EPS decline in 2020; however this is expected to be followed by a 66 per cent increase in 2021 and a 28 per cent increase in 2022. Mathematically, we can conclude that Cyclicals EPS in 2022 are up only 10 per cent on 2019, a compound annual increase of 3 per cent.

Conversely, the EPS growth from the Technology Sector is 6 per cent in 2020, 17 per cent in 2021 and 18 per cent in 2022.  Hence, EPS for 2022 is forecast to be 45 higher than in 2019, a compound annual growth rate of 13 per cent.

Screen Shot 2020-11-20 at 10.29.25 am

As investors, the question we ask is to what degree does the market look through the valley of earnings in a recession at the sunny uplands in the recovery.

That is with the S&P 500 currently close to a record high at 3,600 points, it is on an historic 2019 PE of 22.0X EPS of $163 and a prospective 2020 PE of 26.5X EPS estimate of $136. This then declines to a prospective 2021 PE of 21.8X EPS estimate of $165; and 2022 PE of 18.7X EPS estimate of $193.

Interestingly, the 2020 EPS estimate of $136; the 2021 EPS estimate of $165; and the 2022 EPS  estimate of $193, are all around 10 per cent higher than the consensus forecast figures made in the darker days following the March 2020 pandemic lows. In simple terms, the recovery from the recession has been somewhat stronger than was then anticipated.

The enthusiasm toward the market seems to reflect a strong recovery in consensus EPS forecasts over 2021 and 2022, particularly in the 13 per cent annualised EPS growth from the Technology Sector over the three years to 2022, combined with the view interest rates will remain near record lows for the foreseeable future.

Our Funds

The Montgomery Fund

  • AUSTRALIA/NZ
  • Concentrated high conviction equities
  • From $25,000
Learn More

Montgomery Global Fund

  • GLOBAL
  • Concentrated high conviction equities
  • From $25,000
Learn More

Montaka Global Access Fund

  • GLOBAL
  • Access long/short global equity portfolio
  • From $50,000
Learn More

Montgomery Global Equities Fund (ASX:MOGL)

  • GLOBAL
  • Concentrated high conviction equities
  • No minimum investment - see your broker limits
Learn More

Montgomery Small Companies Fund

  • AUSTRALIA/NZ
  • Concentrated high conviction equities
  • From $25,000
Learn More
Close

Our Funds

Concentrated High Conviction Equities

Listed

Montgomery Global Equities Fund (ASX:MOGL)

Global
Available on the ASX as an Exchange Traded Managed Fund, invests in 15 to 30 quality global businesses for long-term capital growth with a target distribution yield of 4.5% per annum. Mirrors the strategy of the Montgomery Global Fund.
Unlisted From $25,000

Montgomery Global Fund

Global
Invests in 15 to 30 quality global businesses for long-term capital growth. Priced daily. Mirrors the strategy of the Montgomery Global Equities Fund (ASX:MOGL).
Unlisted from $25,000

The Montgomery Fund

Australia/NZ
Aims to provide long-term growth and income by investing in 20 to 40 high-quality Australian and New Zealand businesses trading at attractive valuations. Priced daily.
UNLISTED FROM $25,000

Montgomery Small Companies Fund

Australia/NZ
Aims to provide long-term growth by investing in 30 to 50 high quality, undervalued, Australian and NZ small and emerging companies with strong growth potential. Priced daily.
Unlisted from $1 Million

The Montgomery [Private] Fund

Australia/NZ
Seeks to deliver absolute returns from a portfolio of high-quality Australian and New Zealand businesses. Capital preservation is paramount. By invitation only.

Alternate Equity Strategies

New Fund

Montaka Global Extension Fund (ASX: MKAX)

GLOBAL
An ASX-quoted managed fund, typically, the Fund seeks to hold 15 to 30 long positions and partially offsets these with 10 to 40 short positions, operating with 130% exposure to its long portfolio and 30% exposure to its short portfolio, resulting in a net market exposure of around 100%. Features a target distribution yield of 5% per annum.
Unlisted from $50,000

Montaka Global Access Fund

Global
Aims to generate materially higher risk-adjusted returns, net of fees, than is generally available in the equities market over the medium term. Priced monthly. Provides retail investors access to the Montaka Global Fund.
Unlisted from $1million

Montaka Global 130/30 Fund

Global
Provides the opportunity to benefit from both the gains of extraordinary businesses and the declines of deteriorating businesses through a global equity active extension strategy, which has the potential to significantly outperform the broader equities market over time. Seeks to generate double-digit annual average returns, net of fees. Daily priced.
Unlisted From $1 Million

Montaka Global Fund

Global
Aims to generate materially higher risk-adjusted returns, net of fees, than is generally available in the equities market over the medium term. By invitation only.